| # | Drug | Count |
|---|---|---|
| 0 | CARBOPLATIN | 25 |
| 1 | BEVACIZUMAB | 23 |
| 2 | PACLITAXEL | 22 |
| 3 | PACLITAXEL (AIBUMIN-BOUND) | 22 |
| 4 | ADALIMUMAB | 21 |
| 5 | INFLIXIMAB | 14 |
| 6 | METHOTREXATE SODIUM | 12 |
| 7 | AZATHIOPRINE | 11 |
| 8 | METHOTREXATE | 10 |
| 9 | ADALIMUMAB-AATY | 9 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | TISOTUMAB VEDOTIN | 4 | 0.0041 |
| 1 | ENALAPRIL MALEATE AND HYDROCHLOROTHIAZIDE | 1 | 0.0011 |
| 2 | DOSTARLIMAB | 2 | 0.0008 |
| 3 | TAMOXIFEN CITRATE | 4 | 0.0007 |
| 4 | HYALURONATE SODIUM | 1 | 0.0007 |
| 5 | HALOPERIDOL DECANOATE | 1 | 0.0006 |
| 6 | FELBAMATE | 1 | 0.0006 |
| 7 | MITOMYCIN | 2 | 0.0005 |
| 8 | ESTRADIOL AND LEVONORGESTREL | 1 | 0.0005 |
| 9 | TOPOTECAN | 2 | 0.0003 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Provitamin D2 Compound [EPC] | 7 | 0.0002 |
| 1 | Calcitonin Gene-related Peptide Receptor Antagonist [EPC] | 1 | 0.0001 |
| 2 | Interleukin-17A Antagonist [EPC] | 5 | 0.0001 |
| 3 | Microtubule Inhibitor [EPC] | 22 | 0.0001 |
| 4 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 24 | 0.0001 |
| 5 | Purine Antimetabolite [EPC] | 12 | 0.0001 |
| 6 | Integrin Receptor Antagonist [EPC] | 10 | 0.0001 |
| 7 | Platinum-based Drug [EPC] | 28 | 0.0001 |
| 8 | Antifibrinolytic Agent [EPC] | 1 | 0.0001 |
| 9 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 10 | 0.0001 |